CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 20 | -39.4% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 33 | 0.0% | 0.00% | – |
| Q1 2021 | $96,000 | – | 33 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 689,551 | $593,000 | 0.00% |